These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5097)

  • 1. Activation of the O-glucuronide of the carcinogen N-hydroxy-N-2-fluorenylacetamide by enzymatic deacetylation in vitro: formation of fluorenylamine-tRNA adducts.
    Cardona RA; King CM
    Biochem Pharmacol; 1976 May; 25(9):1051-6. PubMed ID: 5097
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of carcinogenic arylhydroxamic acids by human tissues.
    King CM; Olive CW; Cardona RA
    J Natl Cancer Inst; 1975 Aug; 55(2):285-7. PubMed ID: 1159819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucuronide formation in the metabolism of N-substituted aryl compounds.
    Irving CC
    Natl Cancer Inst Monogr; 1981 Dec; (58):109-11. PubMed ID: 7341967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-sulfonation of N-hydroxy-2-fluorenylacetamide and 7-hydroxy-N-2-fluorenylacetamide in fetal and placental tissues of humans and guinea pigs.
    Namkung MJ; Zachariah PK; Juchau MR
    Drug Metab Dispos; 1977; 5(3):288-94. PubMed ID: 17528
    [No Abstract]   [Full Text] [Related]  

  • 5. Absorption and protein binding of N-2-fluorenylacetamide and its metabolites in the bladder of rabbit.
    Hopp ML; Matsumoto M; Lee C; Oyasu R
    J Natl Cancer Inst; 1977 Feb; 58(2):281-5. PubMed ID: 833876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species difference in liver microsomal and cytosolic enzymes involved in mutagenic activation of N-hydroxy-N-2-fluorenylacetamide.
    Kaneda S; Seno T; Takeishi K
    J Natl Cancer Inst; 1981 Sep; 67(3):549-55. PubMed ID: 6944527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of N-hydroxy-2-acetylaminofluorene by liver microsomes.
    Yamazoe Y; Ishii K; Yamaguchi N; Kamataki T; Kato R
    Biochem Pharmacol; 1980 Aug; 29(16):2183-8. PubMed ID: 7426024
    [No Abstract]   [Full Text] [Related]  

  • 8. Electrophilic N-acetoxyaminoarenes derived from carcinogenic N-hydroxy-N-acetylaminoarenes by enzymatic deacetylation and transacetylation in liver.
    Bartsch H; Dworkin M; Miller JA; Miller EC
    Biochim Biophys Acta; 1972 Dec; 286(2):272-98. PubMed ID: 4660457
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of bovine serum albumin on the extent of ortho rearrangement of N-(sulfooxy)-2-fluorenylacetamide and of enzymatically activated N-hydroxy-2-fluorenylacetamide and on the binding of reactive esters to nucleic acids.
    Kolanczyk RC; Gutmann HR; Rutks IR
    Chem Res Toxicol; 1992; 5(2):274-9. PubMed ID: 1643258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of the inhibitory action of p-hydroxyacetanilide on carcinogenesis by N-2-fluorenylacetamide or N-hydroxy-N-2-fluorenylacetamide.
    Mohan LC; Grantham PH; Weisburger EK; Weisburger JH; Idoine JB
    J Natl Cancer Inst; 1976 Apr; 56(4):763-8. PubMed ID: 815562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of N-hydroxy-2-acetylaminofluorene and N-hydroxy-2-aminofluorene by guinea pig liver microsomes.
    Razzouk C; Batardy-Grégoire M; Roberfroid M
    Cancer Res; 1982 Nov; 42(11):4712-8. PubMed ID: 7127306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial oxaloacetate decarboxylase from rat liver.
    Wojtczak AB; Walajtys E
    Biochim Biophys Acta; 1974 May; 347(2):168-82. PubMed ID: 4407365
    [No Abstract]   [Full Text] [Related]  

  • 13. Dietary lipid-dependent activation of the carcinogen N-2-fluorenylacetamide in rats as monitored by Salmonella typhimurium.
    Castro CE; Felkner IC; Yang SP
    Cancer Res; 1978 Sep; 38(9):2836-41. PubMed ID: 354780
    [No Abstract]   [Full Text] [Related]  

  • 14. N-Hydroxylation of arylamides by the rat and guinea pig. Evidence for substrate specificity and participation of cytochrome P1-450.
    Gutmann HR; Bell P
    Biochim Biophys Acta; 1977 Jun; 498(1):229-43. PubMed ID: 884151
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic activation of N-hydroxy compounds by conjugation.
    Irving CC
    Xenobiotica; 1971; 1(4):387-98. PubMed ID: 5006106
    [No Abstract]   [Full Text] [Related]  

  • 16. Possible role of the glucuronide conjugate in the biochemical mechanism of binding of the carcinogen N-hydroxy-2-acetylaminofluorene to rat-liver deoxyribonucleic acid in vivo.
    Irving CC; Veazey RA; Russell LT
    Chem Biol Interact; 1969 Oct; 1(1):19-26. PubMed ID: 5407052
    [No Abstract]   [Full Text] [Related]  

  • 17. The conversion of the carcinogen N-hydroxy-2-fluorenylacetamide to o-amidophenols by rat liver in vitro. An inducible enzymatic reaction.
    Gutmann HR; Erickson RR
    J Biol Chem; 1969 Apr; 244(7):1729-40. PubMed ID: 5780838
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolism of N-hydroxy-2-acetylaminofluorene and N-hydroxy-phenacetin by guinea pig liver microsomal enzymes.
    Vaught JB; Glowinski IB; King CM
    Carcinogenesis; 1985 Apr; 6(4):495-9. PubMed ID: 2859126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphoenolpyruvate carboxykinase. I. Its role in gluconeogenesis.
    Hanson RW; Garber AJ
    Am J Clin Nutr; 1972 Oct; 25(10):1010-21. PubMed ID: 4342753
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of N-(deoxyguanosin-8-yl)-2-fluorenamine in DNA of peritoneal serosa and liver after intraperitoneal exposure of rats to N-hydroxy-N-2-fluorenylbenzamide or N-hydroxy-N-2-fluorenylacetamide.
    Malejka-Giganti D; Ritter CL; Fullerton NF; Beland FA
    Carcinogenesis; 1994 Dec; 15(12):2883-90. PubMed ID: 8001251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.